A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

• Status: Completed
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this trial is to understand if adding saxagliptin to metformin therapy is safe and works better than taking either saxagliptin or metformin alone

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Metformin; Pioglitazone; Saxagliptin

Criteria

Inclusion Criteria:

• Type 2 diabetes

• Inadequate blood sugar control

• No current treatment with other medications to lower blood sugar

Exclusion Criteria:

• Major heart, liver or kidney problems

• Pregnant or breast feeding